
A global life sciences leader needed to ensure fast, consistent execution across field teams in a highly regulated industry. With complex clinical data and fast-changing market dynamics, teams struggled to stay aligned on what to say, how to position value, and when to act. Leaders lacked real-time signals on execution quality, as ridealongs were infrequent. They also lacked a system for turning frontline activity into insights at scale.
Reps became the execution backbone across business units. Readiness moved from assumption to measurable signal. The platform enabled teams to prepare for high-stakes conversations, surface what was working in the field, and adapt plays based on frontline feedback.
Ahead of a critical launch, Reps collected hundreds of field reflections—uncovering common objections, tipping points, and proven positioning strategies. These patterns were fed back into the system, informing messaging, refining plays, and enabling faster alignment at scale.
Plays reached over 80%-90% participation, exceeding targets. More than 80% of users completed multiple plays within the first three months.
Frontline input directly shaped messaging and objection handling, closing execution gaps and driving higher stocking decisions.
70% of users reported improved ability to explain complex clinical information. AI analysis showed 98% articulated patient value clearly, and 86% used clinical data effectively.
Field leaders gained a complete signal on execution status across regions, enabling faster action and more strategic targeting.
"[Reps] enables us to act with speed and precision. Our teams are more ready, our messaging is tighter, and we have immediate visibility into how we’re executing nationwide."
Business unit leader
A global life sciences leader with a comprehensive portfolio of innovative therapeutics and medical solutions. The company focuses on advancing patient outcomes through scientific innovation, operational excellence, and strong healthcare partnerships.
